Evaluation of SpeeDx's Ciprofloxacin gyrA Assay for Clinical Care of STD Clinic Patients With Neisseria Gonorrhea
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study aims to test the effectiveness of using of SpeeDx Resistance Plus assay to guide treatment of Neisseria gonorrhoeae (Ng) in a sexual health clinic setting.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• English speaking
• Have access to the internet (via computer or phone) on at least a weekly basis
• Asymptomatic (as defined below)
Locations
United States
Washington
Public Health -- Seattle & King County Sexual Health Clinic
RECRUITING
Seattle
Contact Information
Primary
Angela LeClair
achein@uw.edu
206-744-0489
Time Frame
Start Date: 2022-03-03
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 1800
Treatments
Experimental: N. gonorrhea (gyrA wildtype) -Ciprofloxacin Treatment Arm
Participants who are N. gonorrhea (NG) positive and gyrA WT, will receive ciprofloxacin 500 mg PO x 1.
Related Therapeutic Areas
Sponsors
Leads: University of Washington